Anti-Fungal Agents Market of Middle East and Africa Companies Involved:
Enzon Pharmaceuticals, Inc. Bayer AG, Abbott, GlaxoSmithKline plc, Astellas Pharma In, Novartis AG, Pfizer, Inc., Sanofi-Aventis, Abbott, Merck & Co, Sigma-Aldrich and others.
Anti-Fungal Agents Market of Middle East and Africa Market Highlight:
The Anti-Fungal Market drivers incorporate rising commonness of fungal contaminations, rising mindfulness, ascent of resistance inadequate populace, for example, geriatrics, ascend in presentation to irresistible operators because of ecological factors, for example, contamination particularly by particulates and horticulture deposits and climatic conditions, for example, stickiness and temperature, word related perils, for example, Jock itch, crowding and so on.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2582 .
Taking all factors into consideration, we expect the Middle East and Africa Anti-Fungal Agents Market to reach around $2.85 billion by 2022 from $2.32 billion in 2015, by the end of the forecast period at a CAGR of 3.5%.
The Middle East and Africa anti-fungal agents market is led by Azoles followed by Echinocandins. The Azole class is represented in the market by agents such as Noxafil, Vfend, and Diflucan.
The market restraints include rising resistance to anti-fungal agents, use of air filters and air conditioning, excellent spectrum and efficacy of Azole class of anti-fungal agents, loss of patents and genericitization etc. Competition by generics is exceptionally strong and generics account for roughly 50% of total sales for anti-fungal agents.
Drug class; market is segmented into azoles, pyrimidines, echinocandins, polyenes, allylamines, and others.
Route of administration; market is segmented into oral, local and others.
On the basis of therapeutic indication which comprises into aspergillosis, dermatophytosis, candidiasis and others.
Regional Analysis of Middle East and Africa Anti-fungal agents Market:
Overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
UAE is the largest market for anti-fungal agents in entire Middle East and Africa anti-fungal agents Market closely followed by Egypt. The rest of Africa market is however the fastest growing with a huge unmet medical needs and peculiar climatic conditions that support growth of fungal infections.
Table Of Contents:
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Middle East And Africa Anti-Fungal Agents Market, By Therapeutic Indication
6 Middle East And Africa Anti-Fungal Agents Market, By Drug Class
7 Middle East And Africa Anti-Fungal Agents Market, By Route Of Administration
8 Middle East And Africa Anti-Fungal Agents Market, By Country
9 Company Landscape
10 Company Profile
List Of Tables
Table 1 Middle East And Africa Anti-Fungal Agents Market, 2013-2022 (USD Million)
Table 2 Middle East And Africa Anti-Fungal Agents Market, By Therapeutic Indication, 2013-2022 (USD Million)
Table 3 Middle East And Africa Anti-Fungal Agents Market, By Drug Class, 2013-2022 (USD Million)
Table 4 Middle East And Africa Anti-Fungal Agents Market, By Route Of Administration, 2013-2022 (USD Million)
Table 5 Middle East And Africa Anti-Fungal Agents Market, By Region, 2013-2022 (USD Million)
Get Discount @ https://www.marketresearchfuture.com/check-discount/2582 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
+1 646 845 9312
- 1Avg Daily Vews
- 1 Day
- 1 Week
- 1 Month
- 2 Months
- 6 Months
- 1 Year